Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for Prevention of Placental-Mediated Pregnancy Complications
NCT01388322Phase 3Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Mar 2012
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in placental insufficiency, preeclampsia, sponsored by Vall d'Hebron Research Institute. Started Mar 2012; status: completed.
02
Drugs
enoxaparin
03
Conditions
placental insufficiencypreeclampsia
Beyond the preview
Go deeper on NCT01388322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01388322.